%0
Generic
%T
A Phase II Study of Single-Agent Inotuzumab Ozogamicin in Pediatric CD22-Positive Relapsed/Refractory Acute Lymphoblastic Leukemia: Results of the ITCC-059 Study
%A Brivio, Erica
%A Locatelli, Franco
%A Thano, Adriana
%A Petit, Arnaud
%A Vormoor, Britta Julia
%A Rives, Susana
%A Bielorai, Bella
%A Rossig, Claudia
%A Rizzari, Carmelo
%A Van Der Velden, Vincent H.J.
%A Ammerlaan, Anneke C.J.
%A Den Boer, Monique L.
%A Sleight, Barbara
%A Engstler, Gernot
%A Stary, Jan
%A Bautista Sirvent, Francisco José
%A Chen-Santel, Christiane
%A Bruno, Bénédicte
%A Bertrand, Yves
%A Rialland, Fanny
%A Plat, Geneviève
%A Reinhardt, Dirk
%A Vinti, Luciana
%A von Stackelberg, Arend
%A Zwaan, Christian Michel
%I American Society of Hematology
%@ 0006-4971
%@ 1528-0020
%K Cell Biology
%K Hematology
%K Immunology
%K Biochemistry
%D 2020
%C American Society of Hematology
%U http://slubdd.de/katalog?TN_libero_mab2